It has been some 30 years since that, at the Section of Clinical Tumor Virology and Immunology, Department of Medicine, The University of Texas M.D. Anderson Hospital, we established over 50 human tumor cell lines, l among them 25 deriving from sarcomas.
One purpose of the study was a search for causative retroviruses, since from the chicken through mice up to some simian species causative sarcoma viruses were isolated and identified. Filtered supernatant fluids of human sarcoma cell cultures occasionally caused 'antigenic conversion' (as shown by immunofluorescence stains) and 'focus formation' in cultures of human embryonic fibroblasts. 2 These phenomena could not be propagated by passages and yielded no human sarcoma viral isolates, even though transmission EM pictures showed rare retroviral particles in some of these cells. 3 Some xenotropic murine retroviral particles showed up in cultured human sarcoma cells xenografted into nude mice. 1 Another purpose of the study was to test autologous and allogeneic patient lymphocytes for cytotoxicity against cultured sarcoma cells and correlate these reactions with the clinical course of the patients. 4, 5 Some spectacular interaction between sarcoma cells and lymphocytes occurred and were photographed. Allogeneic large lymphocytes with granular cytoplasm lysed sarcoma cells; smaller autologous lymphocytes with thinner rim of cytoplasm and compact nucleus caused clumping in the nuclei of sarcoma cells. [6] [7] [8] These purely morphological observations gained their explanations later when NK cells and their derivatives (LAK cells) with their receptors recognizing malignantly transformed cells (KIRs; NKp30,44,46; NKG2D) and subtypes of immune T cells (TIL) were separated; and perforins of lymphocyte origin and death ligands and their receptors (TNFa; FasL! FasR CD95) inducing extrinsic apoptosis were discovered elsewhere. Furthermore nuclear clumping and death of the lymphocytes attacking sarcoma cells also occurred: the 'counterattack on lymphocytes', while sarcoma cells remained intact 8, 9 (Fig. 1) ; these pictures were taken long before the discovery of the Fas system. A third and main purpose of these studies was the preparation of 'viral oncolysates' from some of these cell lines for active tumor-specific immunotherapy against sarcomas 10 and melanoma. 11, 12 Our work as reported biannually in the institutional Research Report from 1960 to 1978 preceded the discovery of oncogenes whereby a retrovirus transduces a cellular protooncogene (for example c-myc, c-sis, c-src, etc.) and thus gains oncogenicity; 13 and it was carried out in the absence of the as yet undiscovered monoclonal antibodies 14 for lymphocyte subtyping. Decades have since gone by and we still do not have an established human sarcoma vaccine to prevent potsurgical relapses and we do not effectively utilize immune lymphocytes for adoptive immunotherapy of metastatic disease.
We now know that our aim at establishing human tumor cell lines was misdirected. When we forcefully and with great efforts separated tumor cells from normal connective tissue cells that accompanied them and changed media diligently, even on weekends, we deprived our cultures of the as yet undiscovered paracrine growth factors and thus selected It was especially difficult to establish cell lines from classical pre-AIDS Kaposi's sarcoma (KS) tumors: we continued to refresh the media of their primary cultures sometimes daily and did not use 'conditioned media'. In addition to herpesviruses (CMV; EBV in the B-lineage lymphocytes infiltrating the tumor; and now HHV-8), KS cells occasionally displayed budding retrovirus particles 15, 16 (Fig. 2) . We are now promoting a new working hypothesis that a retroviral dsDNA provirus deprived of env gene (but occasionally capable of acquiring one) exists in these cells inserted next to the int-bFGF gene family, which is thus transactivated and amplified to encode bFGF. When excess bFGF ligands are released and captured by their receptors as expressed by the same cells, an autocrine growth loop is established. The recent outstanding report 17 from the same institution recognizes the interaction whereby subverted stromal cells serve the tumor cells with growth factors of paracrine origin. This is a highly generalized phenomenon 12 and it is applicable to many tumors other than sarcomas. For example, certain melanoma cells use the Fas ligand (L) as an autocrine-paracrine growth factor; 18 neuroblastoma cells are driven to grow by TNFa; 19 lymphoma cells armed with FasL kill host immune T cells; 20 and CLL cells are protected from apoptosis by IFNg or by stromal cell-derived factor-1 (SDF-1) released from subverted fibroblast-like cells of the host. 20 While the c-sis-product PDGF and molecular mediators of neoangiogenesis (bFGF; VEGF and their receptors) are well recognized growth factors for sarcoma cells, SDF-1 has not as yet received the attention it deserves.
